|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3-4
|
|
pubmed:dateCreated |
2004-11-23
|
|
pubmed:abstractText |
This study investigated the maximum-tolerated dose of hyperfractionated radiation therapy with protracted 5-fluorouracil (5-FU) infusion in patients with locally advanced, unresectable pancreatic cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
215-21
|
|
pubmed:meshHeading |
pubmed-meshheading:15557781-Adenocarcinoma,
pubmed-meshheading:15557781-Adult,
pubmed-meshheading:15557781-Aged,
pubmed-meshheading:15557781-Antimetabolites, Antineoplastic,
pubmed-meshheading:15557781-Dose Fractionation,
pubmed-meshheading:15557781-Drug Administration Schedule,
pubmed-meshheading:15557781-Female,
pubmed-meshheading:15557781-Fluorouracil,
pubmed-meshheading:15557781-Humans,
pubmed-meshheading:15557781-Infusions, Intravenous,
pubmed-meshheading:15557781-Male,
pubmed-meshheading:15557781-Middle Aged,
pubmed-meshheading:15557781-Pancreatic Neoplasms,
pubmed-meshheading:15557781-Survival Analysis,
pubmed-meshheading:15557781-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
|
|
pubmed:affiliation |
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. hiueno@ncc.go.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase I
|
